Literature DB >> 21902543

Red blood cell engineering in stroma and serum/plasma-free conditions and long term storage.

Hyun Ok Kim1, Eun Jung Baek.   

Abstract

In vitro generation of artificial red blood cells (RBCs) is very important to overcome insufficient and unsafe blood supply. Despite recent progresses in RBCs engineering from several stem cell sources, none of them could succeed in generation of functional RBCs in the absence of serum/plasma and feeder cells. Without the elimination of serum and plasma, human RBC engineering in a large scale is impossible, especially for the future bioreactor system. Using an appropriate combination of cost-effective and safe reagents, the present study demonstrated the terminal maturation of hematopoietic stem cells into enucleated RBCs, which were functional comparable to donated human RBCs. Surprisingly, the viability of erythroid cells was higher in our serum- and feeder-free culture condition than in the previous serum-added condition. This was possible by supplementation with vitamin C in media and hypothermic conditions. Also, our report firstly presents the storability of artificial RBCs, which possibility is essential for clinical application. In summary, our report demonstrates engineering of human applicable RBCs with a dramatically enhanced viability and shelf-life in both serum- and stroma-free conditions. This innovative culture technology could contribute to the realization of the large-scale pharming of human RBCs using bioreactor systems.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21902543     DOI: 10.1089/ten.tea.2010.0711

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  6 in total

Review 1.  The potential of stem cells as an in vitro source of red blood cells for transfusion.

Authors:  Anna Rita Migliaccio; Carolyn Whitsett; Thalia Papayannopoulou; Michel Sadelain
Journal:  Cell Stem Cell       Date:  2012-02-03       Impact factor: 24.633

2.  Superior survival of ex vivo cultured human reticulocytes following transfusion into mice.

Authors:  Sabine Kupzig; Stephen F Parsons; Elinor Curnow; David J Anstee; Allison Blair
Journal:  Haematologica       Date:  2016-12-01       Impact factor: 9.941

3.  Large-Scale Ex Vivo Generation of Human Red Blood Cells from Cord Blood CD34+ Cells.

Authors:  Yu Zhang; Chen Wang; Lan Wang; Bin Shen; Xin Guan; Jing Tian; Zhihua Ren; Xinxin Ding; Yupo Ma; Wei Dai; Yongping Jiang
Journal:  Stem Cells Transl Med       Date:  2017-06-15       Impact factor: 6.940

Review 4.  In-vitro stem cell derived red blood cells for transfusion: are we there yet?

Authors:  Hyun Ok Kim
Journal:  Yonsei Med J       Date:  2014-03       Impact factor: 2.759

5.  Erythropoietic potential of CD34+ hematopoietic stem cells from human cord blood and G-CSF-mobilized peripheral blood.

Authors:  Honglian Jin; Han-Soo Kim; Sinyoung Kim; Hyun Ok Kim
Journal:  Biomed Res Int       Date:  2014-05-05       Impact factor: 3.411

6.  The opposing roles of the mTOR signaling pathway in different phases of human umbilical cord blood-derived CD34+ cell erythropoiesis.

Authors:  Qian Liu; Linhong Luo; Chunhong Ren; Muping Zou; Siqin Yang; Bozhi Cai; Libiao Wu; Yunsheng Wang; Shan Fu; Xu Hua; Nianping Tang; Shiping Huang; Xianxi Huang; Wen Xin; Feiheng Chen; Xin Zhang
Journal:  Stem Cells       Date:  2020-09-01       Impact factor: 6.277

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.